August 19, 2021 -- Curia plans to expand its commercial manufacturing capacity at its facility in Rensselaer, NY, and is investing more than $35 million in the expanded manufacturing and product-handling capabilities for complex small molecules.
Curia, formerly known as Albany Molecular Research, said the expansion will include new vessel capacities that more than double the site's batch-size scaling and product output. It will allow for the introduction of a variety of new products and enable Curia to meet growing demand for high-potency active pharmaceutical ingredient (API) manufacturing.
Curia's Rensselaer, NY, facility. Image courtesy of Curia.
The expansion will generate new jobs in Rensselaer and is expected to be completed within 18 months, the company said.
Copyright © 2021 scienceboard.net